To Be Discontinued Syrup Analgesia/Addiction
Homatropine Methylbromide an · 365 days since initial FDA posting
Brand: HYDROMET
FDA lists Homatropine Methylbromide an as To Be Discontinued (Teva Pharmaceuticals USA, Inc.).
No availability text on this FDA row.
Homatropine Methylbromide and Hydrocodone Bitartrate Syrup: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Homatropine Methylbromide and Hydrocodone Bitartrate Syrup
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Dosage Form
- Syrup
- Presentation
- Hydromet, Syrup, 1.5 mg/5 mL; 5 mg/5 mL (NDC 0472-1030-16)
- Package NDC
- 0472-1030-16
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Sep 11, 2025
- Last Updated
- Sep 11, 2025
- Therapeutic Category
- Analgesia/Addiction
Row fields from the FDA Drug Shortages database via openFDA.